Form D — Angiocrine Bioscience, Inc.
0001569052-25-000002 · filed Sep 5, 2025
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $3,000,000
- Total sold
- $2,100,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Angiocrine Bioscience, Inc.
- CIK
- 1569052
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 11585 SORRENTO VALLEY RD, STE 109
SAN DIEGO, CA 92121 - Phone
- 858-436-8047
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Paul W Finnegan · Executive OfficerSan Diego, CA Find on LinkedIn ↗
-
Jeffrey L Port · DirectorSan Diego, CA Find on LinkedIn ↗
-
David Parkinson · DirectorSan Diego, CA Find on LinkedIn ↗
-
John T Lomoro · Executive OfficerSan Diego, CA Find on LinkedIn ↗
-
John R Jaskowiak · Executive OfficerSan Diego, CA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗